MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Familial neurodegenerative diseases"

  • 2017 International Congress

    Neuroferritinopathy pedigree in 2 families from India

    J. Kaur, G. Singh, B. Paul (Ludhiana, India)

    Objective: The abstract provides description of first case report of two Indian families with Neuroferritinopathy (NFT) pedigree. Background: NFT is a rare autosomal dominant movement disorder caused…
  • 2017 International Congress

    Genotype-phenotype correlations in Parkinson disease patients who carry mutations in the GBA gene.

    A. Thaler, T. Gurevich, A. Ezra, M. Kestenbaum, N. Giladi, A. Mirelman (Tel Aviv, Israel)

    Objective: To assess genotype-phenotype relationship between mild and severe GBA mutation carriers among patients with Parkinson's disease  Background: Mutations in the Glucocerebrocidase gene (GBA) are…
  • 2017 International Congress

    A neuronal model of PARK20 (SYNJ1 mutation) using patient derived iPSCs

    R. Masius, M. Minneboo, M. Grochowska, M. Quadri, M. Picillo, P. Barone, V. Bonifati, W. Mandemakers (Rotterdam, Netherlands)

    Objective: The SYNJ1 homozygous mutation (p.Arg258Gln) leads to juvenile Parkinsonism (PARK20). SYNJ1 plays an important role in synaptic vesicle cycling, and regulating autophagic flux. We…
  • 2017 International Congress

    Interest in Genetic Testing in Parkinson’s disease patients with DBS

    A. Fraint, G. Pal, C. Timms, E. Tam, R. Bhavsar, L. Verhagen, D. Hall, K. Marder (Chicago, IL, USA)

    Objective: To determine interest in genetic testing among Parkinson’s disease (PD) patients with deep brain stimulation (DBS). Background: Nearly 27% of patients with early-onset PD…
  • 2017 International Congress

    Impulse Control Disorders in Early Onset and Familial PD

    R. Rees, N. Williams, Y. Ben-Shlomo, D. Grosset, H. Morris (London, United Kingdom)

    Objective: To characterize impulse control problems in early onset and familial PD (EOPD and FPD). Background: Impulse control disorders are a set of pathological behaviours…
  • 2017 International Congress

    Glucocerebrosidase mutations in neurodegenerative disorders other than Parkinson’s disease

    G. Buongarzone, C. Fenoglio, J. Nicoli, E. Monfrini, I. Trezzi, A. Arighi, R. Del Bo, N. Bresolin, E. Scarpini, G. Comi, S. Corti, A. Di Fonzo (Milan, Italy)

    Objective: To determinate the frequencies of lysosomal glucocerebrosidase (GBA) common mutations in a large sample of neurodegenerative diseases including Alzheimer Disease (AD), Lewy Body Dementia (LBD), Amyotrophic…
  • 2016 International Congress

    Atypical parkinsonism in C9orf72 expansions: A case report and systematic review of 45 cases from the literature

    C. Wilke, J.K. Pomper, S. Biskup, C. Puskás, D. Berg, M. Synofzik (Tübingen, Germany)

    Objective: To provide a systematic clinical characterisation of C9orf72-associated parkinsonism. Background: While C9orf72 repeat expansions usually present with frontotemporal dementia (FTD) and/or amyotrophic lateral sclerosis…
  • 2016 International Congress

    Preliminary results for a study on quality of life in Huntington’s disease patients and their caregivers in Peru

    A. Vishnevetsky, M.A. Inca-Martinez, M. Illanes-Manrique, M. Cornejo-Olivas (Lima, Peru)

    Objective: To quantitatively and qualitatively explore the determinants of quality of life (QOL) in Huntington's Disease (HD) patients and their caregivers in Peru. Background: HD…
  • 2016 International Congress

    A clinico-genetical study in a large cohort of patients with spastic paraplegia type 4 (SPG4)

    A. Orlacchio, M. Mearini, L. Pedace, A. Casella, C. Montecchiani, F. Gaudiello, M. Maurialuisa, R. Massa, C. Caltagirone, R.P. Munhoz, J.L. Pedroso, O.G.P. Barsottini, T. Kawarai (Rome, Italy)

    Objective: This study includes the evaluation of a comprehensive spectrum of neurological features and the mutational screening of the SPG4/SPAST gene in patients with hereditary…
  • 2016 International Congress

    No RAB39B gene mutations in Chinese familial Parkinson’s disease

    J.F. Guo, J.F. Kang, X.X. Yan, B.S. Tang (Changsha, People's Republic of China)

    Objective: To validate the susceptibility to familial PD patients caused by RAB39B in Chinese Han population. Background: Recently, RAB39B mutations c.503C>A and c.574G>A have been…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley